These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
539 related items for PubMed ID: 17083372
1. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model. Zavala-Spinetti L, Breslin MB, Correa H, Bégué RE. Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372 [Abstract] [Full Text] [Related]
6. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Shi T, Liu WZ, Gao F, Shi GY, Xiao SD. Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317 [Abstract] [Full Text] [Related]
7. [Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice]. Lin HJ, Yang Q, Li J, Liu Y, Wang QY. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):436-7. PubMed ID: 18359706 [Abstract] [Full Text] [Related]
8. A plasmid immunization construct encoding urease B of Helicobacter pylori induces an antigen-specific antibody response and upregulates the expression of beta-defensins and IL-10 in the stomachs of immunized mice. Hatzifoti C, Bajaj-Elliott M, Dorrell N, Anyim M, Prentice MB, Nye KE, Wren B, Morrow WJ. Vaccine; 2004 Jun 30; 22(20):2651-9. PubMed ID: 15193391 [Abstract] [Full Text] [Related]
9. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori. Zhang H, Liu M, Li Y, Zhao Y, He H, Yang G, Zheng C. Protein Expr Purif; 2010 Feb 30; 69(2):127-31. PubMed ID: 19651219 [Abstract] [Full Text] [Related]
10. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Zhao W, Wu W, Xu X. Vaccine; 2007 Nov 01; 25(44):7664-73. PubMed ID: 17913305 [Abstract] [Full Text] [Related]
17. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen. Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A. Helicobacter; 2009 Oct 01; 14(5):135-43. PubMed ID: 19751439 [Abstract] [Full Text] [Related]
18. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Zhang HX, Qiu YY, Zhao YH, Liu XT, Liu M, Yu AL. Mol Cell Probes; 2014 Feb 01; 28(1):25-30. PubMed ID: 24036137 [Abstract] [Full Text] [Related]
19. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model. Guo L, Yin R, Liu K, Lv X, Li Y, Duan X, Chu Y, Xi T, Xing Y. Appl Microbiol Biotechnol; 2014 Apr 01; 98(8):3495-507. PubMed ID: 24370888 [Abstract] [Full Text] [Related]
20. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. Yang XL, Liu WC, Yang WW, Zhong D, Liu YH, Zhang JD, Jiang JH, Li SS. Biomed Environ Sci; 2005 Dec 01; 18(6):411-8. PubMed ID: 16544523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]